Overview
- 81 inspections across 73 sites are on record.
- 24 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
81
Sites
73
Observations
24
Career since
Oct 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Coby E Rudakewiz DVM | 15 May 2026 | Animal Drugs & Feeds | |
| Clario Inc. | 22 Apr 2026 | Human Drugs | |
| Clario Inc. | 23 Feb 2026 | Human Drugs | |
| Gautam T. Jayram, M.D. | 23 Jan 2026 | Human Drugs | On file |
| Cooper Health System IRB | 4 Dec 2025 | Medical Devices & Rad Health | On file |
Sites inspected
Coby E Rudakewiz DVMHarrisburg, United States1 insp.
Clario Inc.Philadelphia, United States2 insp.
Gautam T. Jayram, M.D.Nashville, United States1 insp.
Cooper Health System IRBCamden, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Anastasia I Onuorah6 shared
Joseph L Despins4 shared
Stephanie C Mangigian3 shared
Brandy D Brown2 shared
Daniel P Laucks1 shared
Kerun Hardeo1 shared
Erin M Mcdowell1 shared
Mark J Seaton1 shared
Dawn C Olenjack1 shared
Lucilla Facchin1 shared
Full investigator report
Get the verbatim findings behind Gabrielle J Swain's 24 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site